SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), the world leader in the development of a new class of small molecule compounds based on endogenous adrenal steroid hormones, announced that it will present at the Merriman Curhan Ford 5th Annual Investor Summit in San Francisco at 3:00 p.m. PDT on September 15, 2008. Presenting on behalf of the Company will be Richard B. Hollis, Chairman and Chief Executive Officer. A live webcast of the presentation will be available from the conference. Investors may access the webcast under “Event Calendar” on the Investors section of Hollis-Eden’s website at www.holliseden.com. The webcast will be archived at the Company’s website for 30 days following the presentation.
